Home › NDC Lookup › RxCUI directory › RxCUI 998426

Acyclovir 50 MG/ML / hydrocortisone 10 MG/ML Topical Cream [Xerese] — RxCUI 998426

RxNorm drug concept · Semantic branded drug
RxCUI 998426 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI998426
Official nameAcyclovir 50 MG/ML / hydrocortisone 10 MG/ML Topical Cream [Xerese]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXerese (acyclovir 5 % / hydrocortisone 1 % ) Topical Cream; acycycloguanosine 50 MG/ML / Hydrocortisone 10 MG/ML Topical Cream [Xerese]
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acyclovir Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Acyclovir cream is used to treat cold sores — those small, painful blisters that appear on or around the lips, caused by the herpes simplex virus. It's approved for adults and teen...
  • What exactly is acyclovir cream used for?
  • The sooner the better — ideally at the very first tingle or sign of a cold sore coming on. For the ointment form, the standard schedule is every 3 hours, 6 times a day, for 7 days....
  • When should I start applying it, and how often?
📖 Read our full Acyclovir Topical guide →

🕸️ Concept Web — How Acyclovir 50 MG/ML / hydrocortisone 10 MG/ML Top... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acyclovir 50 MG/ML / hydrocortisone 10 MG/ML Topical Cream [Xerese] RxCUI 998426

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Acyclovir 281
    • Hydrocortisone 5492
    • Acyclovir / hydrocortisone 1007804
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xerese 998423
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acyclovir / hydrocortisone Topical Cream 998421
    • Acyclovir / hydrocortisone Topical Product 1153457
    • Acyclovir / hydrocortisone Topical Cream [Xerese] 998425
    • Xerese Topical Product 1186419
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Acyclovir 50 MG/ML / hydrocortisone 10 MG/ML [Xerese] SBDC · 998424
  • Acyclovir / hydrocortisone Topical Cream [Xerese] SBDF · 998425
  • Xerese Topical Product SBDG · 1186419
  • Xerese BN · 998423

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 998426 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-5104-01 1 TUBE in 1 CARTON (0187-5104-01) / 5 g in 1 TUBE Xerese Bausch Health US LLC 2009-07-31
Observed labelers: Bausch Health US LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.